Capnoidine is a potential new anti-inflammatory drug lead candidate for diseases where current standard-of-care often fails and is associated with major side effects. It also validates the traditional uses of C. dubia against inflammatory conditions and underlines the value of pursuing bioactive compounds derived from traditionally used ethnobotanical medicines. References: Shepherd C, Giacomin P, Navarro S, Miller C, Loukas A, Wangchuk P. A medicinal plant compound, capnoidine, prevents the onset of inflammation in a mouse model of colitis. J Ethnopharmacol. 2018 Jan 30;2117-28. doi: 10.1016/j.jep.2017.09.024. Epub 2017 Sep 21. PubMed PMID: 28942135.

纯度：≥98%

CAS：485-50-7